Dr Colleen Hanlon
Dr. Colleen A. Hanlon is a professor in the Department of Cancer Biology at Wake Forest University Health Sciences, wherein she leads a new Electromagnetic Therapeutics Research Program. The majority of her research is focused on developing evidence-based TMS protocols which may be useful therapeutic tools for patients struggling with addiction. She leads 3 NIH-suported R01 awards and is part of two NIH centers interested in translating preclinical brain stimulation knowledge into a treatment that can be delivered to patients with alcohol and substance use disorders. She was honored with the Early Career Investigator award from the National Institute of Drug Abuse. I am the senior author on the first “Consensus Paper” published by a group of over 70 scientists from over 10 countries outlining the path forward for Non-Invasive Therapeutic Development for Addiction.
She loves science and being a scientist (!!) – the process and the privilege. Perhaps more than the actual data analysis and writing however, she is finds a unique joy in mentoring and nurturing the creative ideas among her students and her colleagues. She participates in the research training and education community at both a local level (serving as a mentor to over 50 medical, graduate, post-graduate, and fellowship trainees since 2005 on a national and international scale) and national level. She has directed the Advanced TMS Training Course sponsored by the National Center for Neuromodulation for Rehabilitation, and continues to be involved in their research dissemination efforts through teaching and management of their social media presence. She has led an annual addiction outreach event at the College of Problems on Drug Dependence (CPDD) meeting (2015-2019), served on the Liaison Committee (2016-2019) and the Education and Training Committee (2019-present) for the American College of Neuropsychopharmacology, Grassroots Advocacy Team for the Society for Neuroscience (2017-2019), Chair of the Education Outreach and Public Policy Committee for CPDD (2017-2019), ad hoc participation in over 20 NIH study sections, and serving as a permanent member of NIH NPAS study section (effective 10/2018).
Dr Colleen Hanlon joins us as a keynote speaker at the Brainbox Initiative Conference 2020, with a talk entitled Oops.. I did it again: Using TMS as a tool to prevent Relapse to Alcohol Drinking.